TY - JOUR
T1 - Prevalence and Patterns of Opioid Use in Chronic Pancreatitis
AU - Phillips, Anna Evans
AU - Conwell, Darwin L.
AU - Li, Shuang
AU - Saloman, Jami L.
AU - Hart, Phil A.
AU - Fogel, Evan L.
AU - Vege, Santhi Swaroop
AU - Andersen, Dana K.
AU - Fisher, William E.
AU - Forsmark, Christopher E.
AU - Pandol, Stephen
AU - Park, Walter G.
AU - Topazian, Mark D.
AU - Van Den Eeden, Stephen K.
AU - Serrano, Jose
AU - Li, Liang
AU - Yadav, Dhiraj
N1 - Publisher Copyright:
© 2025 Lippincott Williams and Wilkins. All rights reserved.
PY - 2025/2/5
Y1 - 2025/2/5
N2 - INTRODUCTION: Opioids are used to treat pain in chronic pancreatitis (CP), but little is known about current use patterns. The aim of this study was to characterize the utilization of opioids and associations with clinical characteristics in adult patients with CP. METHODS: This cross-sectional analysis used baseline data from participants with definite CP enrolled in a cohort study in the United States (PROspective Evaluation of CP for EpidEmiologic and Translational StuDies). Data on demographics, pain medication use, healthcare utilization, disability, and pain patterns were systematically collected in case report forms while quality of life was assessed with patient-reported outcome instruments. Opioid use was classified according to strength (weak or strong) and frequency (scheduled or as-needed). RESULTS: A total of 681 participants (n = 364, 53% male) were included: 299 (44%) were current opioid users (22% only weak opioids and 22% at least 1 strong opioid). Increasing frequency and severity of pain was associated with increase of weak, strong, as-needed, or scheduled opioids. Neuromodulators were used by ∼40% of participants; increasing use was associated with increasing frequency and severity of pain. On multivariate analysis, independent predictors associated with strength and frequency of current opioid use were pain patterns (odds ratios [ORs] 1.84-8.32 and ORs 1.92-8.52, respectively, P < 0.001) and prior celiac plexus block (OR 3.54, 95% confidence intervals 1.82-6.87 and OR 3.42, 95% confidence intervals 1.76-6.64, respectively). Participants using opioids had higher prevalence of disability, healthcare utilization, and poorer quality of life. DISCUSSION: Opioid use in CP is common and associated with increased pain severity and constancy. These data provide foundational estimates for future trials that can elucidate the complex interactions between patient factors, pain, and interventions.
AB - INTRODUCTION: Opioids are used to treat pain in chronic pancreatitis (CP), but little is known about current use patterns. The aim of this study was to characterize the utilization of opioids and associations with clinical characteristics in adult patients with CP. METHODS: This cross-sectional analysis used baseline data from participants with definite CP enrolled in a cohort study in the United States (PROspective Evaluation of CP for EpidEmiologic and Translational StuDies). Data on demographics, pain medication use, healthcare utilization, disability, and pain patterns were systematically collected in case report forms while quality of life was assessed with patient-reported outcome instruments. Opioid use was classified according to strength (weak or strong) and frequency (scheduled or as-needed). RESULTS: A total of 681 participants (n = 364, 53% male) were included: 299 (44%) were current opioid users (22% only weak opioids and 22% at least 1 strong opioid). Increasing frequency and severity of pain was associated with increase of weak, strong, as-needed, or scheduled opioids. Neuromodulators were used by ∼40% of participants; increasing use was associated with increasing frequency and severity of pain. On multivariate analysis, independent predictors associated with strength and frequency of current opioid use were pain patterns (odds ratios [ORs] 1.84-8.32 and ORs 1.92-8.52, respectively, P < 0.001) and prior celiac plexus block (OR 3.54, 95% confidence intervals 1.82-6.87 and OR 3.42, 95% confidence intervals 1.76-6.64, respectively). Participants using opioids had higher prevalence of disability, healthcare utilization, and poorer quality of life. DISCUSSION: Opioid use in CP is common and associated with increased pain severity and constancy. These data provide foundational estimates for future trials that can elucidate the complex interactions between patient factors, pain, and interventions.
KW - chronic pain
KW - chronic pancreatitis
KW - neuromodulator
KW - opioid
UR - http://www.scopus.com/inward/record.url?scp=85217881533&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85217881533&partnerID=8YFLogxK
U2 - 10.14309/ctg.0000000000000807
DO - 10.14309/ctg.0000000000000807
M3 - Article
AN - SCOPUS:85217881533
SN - 2155-384X
VL - 16
JO - Clinical and Translational Gastroenterology
JF - Clinical and Translational Gastroenterology
IS - 5
ER -